Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan Elizabeth Arnold currently holds 41,236 shares of PhaseBio Pharmaceuticals Inc (PHAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Elizabeth Arnold has been a net neutral trader of PHAS stock. They have purchased $0 and sold $0 worth of shares.
Susan Elizabeth Arnold's most recent insider trade was on May 20, 2022, when they sold 10,917 shares at $0.68 per share.
Susan Elizabeth Arnold serves as Executive at PhaseBio Pharmaceuticals Inc (PHAS). They have executed 9 insider transactions totaling $0 over their tenure at the company.
Susan Elizabeth Arnold holds the position of Executive at PhaseBio Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Susan Elizabeth Arnold has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Susan Elizabeth Arnold was on May 20, 2021, when they purchased $14.7K worth of PHAS shares. This transaction involved 5,257 shares at $2.80 per share.
Susan Elizabeth Arnold currently owns 41,236 shares of PhaseBio Pharmaceuticals Inc (PHAS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan Elizabeth Arnold's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan Elizabeth Arnold has 9 Form 4 filings on record as an insider at PhaseBio Pharmaceuticals Inc.
Set alerts for Susan Elizabeth Arnold and 40,000+ other insiders.